A potent and highly efficacious bivalent Smac mimetic APG-1387 in phase I clinical development
Home » A potent and highly efficacious bivalent Smac mimetic APG-1387 in phase I clinical development
November 20, 2014
Lu J, Sheng R, Sun H, et al. A potent and highly efficacious bivalent Smac mimetic APG-1387 in phase I clinical development. 26th EORTC-NCI-AACR Symposium. vol. Poster 268,